Biotech Jazz Pharmaceuticals News

Jazz Pharmaceuticals Announces Positive Phase 3 Data for Narcolepsy

Biotech News | 26.09.2019

JZP-258, a novel oxybate product candiadate by Jazz Pharmaceutials, was successfully tested in a...